Evaluation of therapeutics and vaccines in mouse models of dengue virus.
Active Awarded Last action
- Contract number
- 75N93026F00001
- Awardee
-
University Of Texas Medical Branch At Galveston UEI MSPWVMXXMN76
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $844,795
Award facts
- Contract value 16% obligated
-
- $844,795.00 Current, with exercised options
- $5,329,933.00 Potential, with all options
- Completion date 10% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Galveston, TX 77555, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to the University of Texas Medical Branch at Galveston on September 15, 2026, with a ceiling value of $5,329,933 for evaluation of therapeutics and vaccines in mouse models of dengue virus under the Pre-Clinical Models of Infectious Diseases IDIQ.
The parent vehicle supports preclinical modeling of infectious diseases across the federal research portfolio. Work is performed in Galveston, TX, with an ultimate completion date of September 14, 2027. The order is priced on a cost-no-fee basis. UTMB operates as an academic research institution and state-controlled entity within the University of Texas System, with federal research capability anchored in high-containment laboratory work, animal model development for infectious disease countermeasures, and translational science spanning viral pathogenesis and drug discovery.
Quick answers
Who was awarded contract 75N93026F00001?
75N93026F00001 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2026.
How much is contract 75N93026F00001 worth?
The government has obligated $844,795 on 75N93026F00001. Its potential value, with all options, is $5,329,933.
Is contract 75N93026F00001 an order under another contract?
Yes. 75N93026F00001 is a delivery order under 75N93024D00042, an indefinite delivery contract, on Pre-Clinical Models of Infectious Diseases.
Was contract 75N93026F00001 competed?
The extent of competition for 75N93026F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award